Jean‐François Héron

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

W ten Bokkel Huinink, Martin Gore, J Carmichael et al. · Journal of Clinical Oncology · 1997 · 681 citations

Quality of Life in Long-Term Survivors of Testicular Cancer: A Population-Based Case-Control Study

Florence Joly, Jean‐François Héron, L. Kalusinski et al. · Journal of Clinical Oncology · 2002 · 141 citations

Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer

F. Joly, D. Brune, J.E. Couette et al. · Annals of Oncology · 1998 · 101 citations · Full text

Quality Of Life, Urology, Radiation Medicine +9

Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP

Stéphane Culine, Andrew Kramar, Christine Théodore et al. · Journal of Clinical Oncology · 2008 · 99 citations · Full text

Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer

Martin Gore, W ten Bokkel Huinink, James Carmichael et al. · Journal of Clinical Oncology · 2001 · 93 citations